Clinical application of interferons in large animal medicine

Journal of the American Veterinary Medical Association

Volumn 208, Issue 10, 1996, Pages 1711-1715

  Moore, Bonnie Rush ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL; ANIMAL DISEASE; ANIMAL PARASITOSIS; BACTERIAL INFECTION; CATTLE; CATTLE DISEASE; DIARRHEA; DOMESTIC ANIMAL; FEMALE; HORSE; HORSE DISEASE; HUMAN; PROTOZOAL INFECTION; RESPIRATORY TRACT INFECTION; REVIEW; VIRUS INFECTION;

ANIMALS; ANIMALS, DOMESTIC; BACTERIAL INFECTIONS; CATTLE; CATTLE DISEASES; DIARRHEA; FEMALE; HORSE DISEASES; HORSES; HUMANS; INTERFERONS; MASTITIS, BOVINE; PROTOZOAN INFECTIONS; PROTOZOAN INFECTIONS, ANIMAL; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 0030585140     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Stanton GJ, Weigent DA, Fleishmann WR, et al. Interferon review. Invest Radiol 1987;22:259-271.
2. Roberts RM. A novel group of interferons associated with early ovine and bovine embryo. J Interferon Res 1989;9:373-377.
3. Baron S, Tyring SK, Fleischmann WR, et al. The interferons: mechanisms of action and clinical applications. JAMA 1991;266: 1375-1383.
4. MacLachlan NJ, Thompson J. Bluetongue virus-induced interferon in cattle. Am J Vet Res 1985;46:1238-1241.
5. Weigent D, Langford M, Stanton G, et al. Interferon-induced transfer of viral resistance by human B and T lymphocytes. Cell Immunol 1984;87:678-683.
6. Karupiah G, Xie QW, Buller ML, et al. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993;261:1445-1448.
7. Horisberger MA, Shrenk R, Staiger S, et al. Induction of Mx-related protein in cat peripheral blood mononuclear cells after administration of recombinant human interferon hybrid. Antiviral Res 1990;13:53-60.
8. Faltynek CR, Oppenheim JJ. Interferons in host defense. J Natl Cancer Inst 1988;80:3.
9. Stanton GJ, Lloyd RE, Sarzotti M, et al. Protection of mice from Semliki Forest virus infection by lymphocytes treated with low levels of interferon. Mol Biother 1989;1:305-310.
10. Holan V, Nakamura S, Minowada J. Inhibitory versus stimulatory effects of natural human interferon-alpha on proliferation of lymphocyte subpopulations, Immunology 1992;75:176-181.
11. Tzung S, Cohen SA. Interferon alpha/beta produced by Kupffer cells inhibits interleukin-1, tumor necrosis factor alpha production and interleukin-2-induced activation of nonparenchymal liver cells. Cancer Immunol Immunother 1991;34:150-156.
12. Philips R, Epstein L. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, interferon and interleukin-1. Nature 1986;323:86-89.
13. Stewart WE II, Gresses I, Tovey MG, et al. Identification of the cell multiplication inhibitory factors in intereron preparations as interferons. Nature 1976;262:300-303.
14. Bridgman R, Rossi CR, Campos M. The sensitivity of domestic animal cell lines to eight recombinant human interferons. J Interferon Res 1988;8:173-175.
15. Gresser I, Bandu MT, Brouty-Boye D. Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature 1974;251:543-545.
16. Kruzel ML, Seman G, Georgiades JA. Molecular species occurring in naturally induced interferon alpha. Arch Immunol Ther Exp (Warsz) 1993;41:179-183.
17. Derynck R, Remaut E, Saman E. Expression of human fibroblast interferon gene in Escherichia coli. Nature 1980;287:193-197.
18. Rubinstein M. Multiple interferon subtypes: the phenomenon and its relevance. J Interferon Res 1987;7:545-551.
19. In: Dianzani F, ed. Collected papers on the significance of multiple human interferon-alpha subtypes. J Interferon Res 1991:1-194.
20. Antonelli G, Currenti M, Turriziani O, et al. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations. J Infect Dis 1991;163:882-885.
21. Roney CS, Rossi CR, Smith PC. Effect of human leukocyte A interferon on prevention of infectious bovine rhinotracheitis virus infection of cattle. Am J Vet Res 1985;46:1251-1255.
22. 2) against experimental vaccinia infection in calves. J Interferon Res 1985;5:129-136.
23. Schwers A, Vanden Broecke C, Maenhoudt M, et al. Experimental rotavirus diarrhoea in colostrum-deprived newborn calves: assay of treatment by administration of bacterially produced human interferon (Hu-1FNa2). Ann Rech Vet 1985;16:213-218.
24. Stanton GJ, Hughes TK, Heard HK, et al. Modulation of a natural virus defense system by low concentrations of interferons at mucosal surfaces. J Interferon Res 1990;S1:99.
25. Georgiades JA. A new approach to chronic viral disease therapy by cytokines. Arch Immunol Ther Exp (Warsz) 1993;41:173-178.
26. Cummins JM, Hutcheson DP, Cummins MJ, et al. Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis. Arch Immunol Ther Exp (Warsz) 1993;41:193-197.
27. Caban J, Mossor-Ostrowka J, Zyrkowska-Bieda T, et al. Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges. Arch Immunol Ther Exp (Warsz) 1993;41:229-236.
28. Georgiades JA. Effect of low dose natural human interferon alpha given into the oral cavity on the recovery time and death loss in feedlot hospital pen cattle: a field study. Arch Immunol Ther Exp (Warsz) 1993;41:205-207.
29. Bocci V. Absorption of cytokines via oropharyngeal-associated lymphoid tissues. Clin Pharmacokinet 1991;21:411-417.
30. Wills RJ, Speigel HE, Soike KF. Pharmacokinetics of recombinant alpha A interferon following IV infusion and bolus, IM, and PO administrations to African green monkeys. J Interferon Res 1984;4:399-409.
31. Diez RA, Perdereau B, Falcoff E. From old results to new perspectives: a look at interferon's fate in the body. J Interferon Res 1987;7:553-557.
32. Rosenquist BD. Induction and biologic significance of interferon, with particular reference to cattle. J Am Vet Med Assoc 1973; 163:821-824.
33. Cummins JM, Rosenquist BD. Protection of calves against rhinovirus infection by nasal secretion interferon induced by infectious bovine rhinotracheitis virus. Am J Vet Res 1980;41:161-165.
34. El Azhary MASY, Silim A, Roy RS. Interferon, fluorescent antibody, and neutralizing antibody responses in sera of calves inoculated with bovine respiratory syncytial virus. Am J Vet Res 1981; 42:1378-1382.
35. Cummins JM, Rosenquist BD. Partial protection of calves against parainfluenza-3 virus infection by nasal-secretion interferon induced by infectious bovine rhinotracheitis virus. Am J Vet Res 1982;43:1334-1338.
36. Babuik LA, Beilefeldt Ohmann H, Gifford G, et al. Effect of bovine-alpha interferon on bovine herpesvirus type 1-induced respiratory disease. J Gen Virol 1985;66:2383-2395.
37. Bryson DG, McNulty MS, Evans RT, et al. Studies of the effect of recombinant human-alpha 1 interferon on experimental parainfluenza type 3 virus infections of the respiratory tract of calves. Vet Rec 1989;125:615-618.
38. Akiyama K, Sugii S, Yoshikazu H. A clinical trial of recombinant bovine interferon alpha, for the control of bovine respiratory disease in calves. J Vet Med Sci 1993;55:449-552.
39. Chiang YW, Roth JA, Andrews JJ. Influence of recombinant bovine interferon gamma and dexamethasone on pneumonia attributable to Haemophilus somnus in calves. Am J Vet Res 1990;51:759-762.
40. Cummins JM, Gawthrop J, Hutcheson DP, et al. The effect of low dose oral human interferon alpha therapy on diarrhea in veal calves. Arch Immunol Ther Exp (Warsz) 1993;41:199-204.
41. Bukholm G, Berdal BP, Haugn C. Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect Immun 1984;45:62-66.
42. 11 on acute Salmonella typhimurium infection in calves. Am J Vet Res 1990;51:1095-1099.
43. Babiuk LA, Sordillo LM, Campos M, et al. Application of interferons in the control of infectious diseases of cattle. J Dairy Sci 1991;74:4385-4398.
44. Sordillo LM, Babiuk LA. Controlling acute Escherichia coli mastitis during the periparturient period with recombinant bovine interferon gamma. Vet Microbiol 1991;28:189-198.
45. Ferreira A, Schofield L, Enea V, et al. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 1986;232:881-884.
46. Young AS, Maritim AC, Kariuki DP, et al. Low-dose oral administration of human interferon alpha can control the development of Theileria parva infection in cattle. Parasitology 1990;101: 201-209.
47. Orinda GO, Wright IG, Leatch G, et al. Human interferon alpha fails to inhibit the development of Babesia bigemina and Anaplasma marginale infections in cattle. Vet Parasitol 1993;47:149-155.
48. Moore BR, Krakowka S, Cummins JM, et al. Oral administration of interferon-alpha for treatment of inflammatory airway disease in Standardbred racehorses. Vet Immunol Immunopathol 1996;49:347-358.
49. McKane SA, Rose RJ, Evans DL. Relationships between bronchoalveolar lavage cytology and gas exchange during exercise in racehorses presented for poor racing performance, in Proceedings. Int Exercise-Induced Pulm Hemorrhage Conf 1993;13-14.
50. Seahorn TL, Carter GK, Martens JG, et al. Effects of human alpha interferon on experimentally induced equine herpesvirus-1 infection in horses. Am J Vet Res 1990;51:2006-2010.